Function, evolution and structure of multidrug resistance protein (MRP)

R G Deeley1, S P Cole

  • 1Cancer Research Laboratories, Queen's University, Kingston, Ontario, Canada.

Insights

Multidrug Resistance Protein (MRP) overexpression in cells causes resistance to natural drugs and is linked to poor chemotherapy response in tumors. MRP likely transports drugs and anions, with a unique structure essential for its function.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Multidrug Resistance Protein (MRP) is implicated in drug resistance when overexpressed in cultured cells.
  • MRP is found in human tumors, with expression correlating to poor chemotherapy outcomes.
  • In normal tissues, MRP likely functions as an active transporter for amphiphilic anions.

Purpose of the Study:

  • To investigate the role of Multidrug Resistance Protein (MRP) in drug resistance.
  • To understand the transport mechanism and structural features of MRP.
  • To explore the evolutionary relationship of MRP with other ATP Binding Cassette superfamily members.

Main Methods:

  • Analysis of MRP expression in cultured cells and human tumors.
  • Investigation of MRP's transport activity for drugs and anions.
  • Structural analysis of MRP, focusing on its membrane-spanning domains.
  • Comparative analysis of gene organization and protein structure with related proteins.

Main Results:

  • MRP overexpression confers resistance to natural product drugs.
  • MRP's unique NH2-proximal domain with five membrane-spanning helices is essential for transport.
  • MRP shares conserved features with the cystic fibrosis conductance regulator, suggesting a common ancestry.

Conclusions:

  • MRP plays a significant role in multidrug resistance and impacts chemotherapy efficacy.
  • The distinct structural domain of MRP is critical for its transporter function.
  • MRP belongs to a protein family with evolutionary links to the cystic fibrosis conductance regulator.

Related Concept Videos

ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...